No abstract available
Publication types
-
Letter
-
Multicenter Study
-
Observational Study
MeSH terms
-
Adalimumab / administration & dosage
-
Adalimumab / adverse effects
-
Aged
-
Biological Products / administration & dosage*
-
Biological Products / adverse effects
-
Dermatologic Agents / administration & dosage*
-
Erysipelas / epidemiology*
-
Erysipelas / immunology
-
Erysipelas / microbiology
-
Etanercept / administration & dosage
-
Etanercept / adverse effects
-
Female
-
France
-
Humans
-
Infliximab / administration & dosage
-
Infliximab / adverse effects
-
Liver / drug effects
-
Liver Cirrhosis, Alcoholic / complications*
-
Liver Cirrhosis, Alcoholic / immunology
-
Male
-
Middle Aged
-
Psoriasis / complications
-
Psoriasis / drug therapy*
-
Psoriasis / immunology
-
Retrospective Studies
-
Ustekinumab / administration & dosage
-
Ustekinumab / adverse effects
Substances
-
Biological Products
-
Dermatologic Agents
-
Infliximab
-
Ustekinumab
-
Adalimumab
-
Etanercept